Daniella Cramp - Net Worth and Insider Trading

Daniella Cramp Net Worth

The estimated net worth of Daniella Cramp is at least $236,135 dollars as of 2024-06-02. Daniella Cramp is the Pres., Chronic Care of Alere Inc and owns about 4,631 shares of Alere Inc (ALR) stock worth over $236,135. Details can be seen in Daniella Cramp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniella Cramp has not made any transactions after 2013-03-01 and currently still holds the listed stock(s).

Transaction Summary of Daniella Cramp

Daniella Cramp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniella Cramp owns 3 companies in total, including Alere Inc (ALR) , Alere Inc (ALRPRB.PFD) , and Acutus Medical Inc (AFIB) .

Click here to see the complete history of Daniella Cramp’s form 4 insider trades.

Insider Ownership Summary of Daniella Cramp

Ticker	Comapny	Transaction Date	Type of Owner
ALR	Alere Inc	2017-10-03	Global Pres. & Cardiometabolic
ALRPRB.PFD	Alere Inc	2017-10-03	Global Pres. & Cardiometabolic
AFIB	Acutus Medical Inc	2021-02-03	director

Daniella Cramp Latest Holdings Summary

Daniella Cramp currently owns a total of 1 stock. Daniella Cramp owns 4,631 shares of Alere Inc (ALR) as of March 1, 2013, with a value of $236,135.

Latest Holdings of Daniella Cramp

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ALR	Alere Inc	2013-03-01	4,631	50.99	236,135

Holding Weightings of Daniella Cramp

Daniella Cramp Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniella Cramp has made a total of 0 transactions in Alere Inc (ALR) over the past 5 years. The most-recent trade in Alere Inc is the sale of 0 shares on March 1, 2013, which brought Daniella Cramp around $0.

Insider Trading History of Daniella Cramp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniella Cramp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniella Cramp Ownership Network

Ownership Network List of Daniella Cramp

No Data

Ownership Network Relation of Daniella Cramp

Daniella Cramp Owned Company Details

What does Alere Inc do?

Who are the key executives at Alere Inc?

Daniella Cramp is the Global Pres. & Cardiometabolic of Alere Inc. Other key executives at Alere Inc include director & Chief Executive Officer Namal Nawana , Senior VP & Global R&D Renuka Uppaluri , and Senior VP & Global Operations Mark Gladwell .

Alere Inc (ALR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alere Inc (ALR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alere Inc (ALR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alere Inc (ALR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alere Inc Insider Transactions

No Available Data

What does Alere Inc do?

Who are the key executives at Alere Inc?

Daniella Cramp is the Global Pres. & Cardiometabolic of Alere Inc. Other key executives at Alere Inc include director & Chief Executive Officer Namal Nawana , GC & Chief Ethics Officer&Sec Ellen Chiniara , and GlobalPres & Infectious Disease Avi Pelossof .

Alere Inc (ALRPRB.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alere Inc (ALRPRB.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alere Inc (ALRPRB.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alere Inc (ALRPRB.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alere Inc Insider Transactions

No Available Data

What does Acutus Medical Inc do?

Who are the key executives at Acutus Medical Inc?

Daniella Cramp is the director of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .

Acutus Medical Inc (AFIB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acutus Medical Inc Insider Transactions

No Available Data

Daniella Cramp Mailing Address

Above is the net worth, insider trading, and ownership report for Daniella Cramp. You might contact Daniella Cramp via mailing address: 51 Sawyer Road, Suite 200, Waltham Ma 02453.

Discussions on Daniella Cramp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.